ELV100 Placebo Tablets clinical trials

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of ELV001 as Add-on Therapy in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

This study is testing a new medicine, ELV001, for people with rheumatoid arthritis whose current treatments (methotrexate and another type of drug) aren't working well enough. We want to see if ELV001 is safe and helps reduce arthritis symptoms.